Revvity, Inc.

RVTY

US7140461093

Advanced Medical Equipment & Technology

Market Closed - Nyse Other stock markets 01:30:02 15/06/2024 am IST			5-day change	1st Jan Change
108.6 ^USD	-1.87%		-2.05%	-0.60%

10/06	Transcript : Revvity, Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-10-2024 08:00 AM
14/05	Transcript : Revvity, Inc. Presents at Bank of America Health Care Conference 2024, May-14-2024 08:40 AM

PerkinElmer, Inc. Provides Earnings Guidance for the Full Year 2019

January 01, 2019 at 02:45 am IST

PerkinElmer, Inc. provided earnings guidance for the full year 2019. For the full year 2019, the Company forecasts GAAP earnings per share from continuing operations in a range of $2.93 to $2.98.

Latest news about Revvity, Inc.

Transcript : Revvity, Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-10-2024 08:00 AM	10/06
Transcript : Revvity, Inc. Presents at Bank of America Health Care Conference 2024, May-14-2024 08:40 AM	14/05
TD Cowen Adjusts Price Target on Revvity to $130 From $123	30/04	MT
JPMorgan Adjusts Price Target on Revvity to $105 From $100, Neutral Rating Maintained	30/04	MT
Baird Adjusts Price Target on Revvity to $127 From $126	30/04	MT
Bernstein Adjusts Price Target on Revvity to $123 From $125, Keeps Outperform Rating	30/04	MT
Nephron Adjusts Revvity's Price Target to $124 From $120	29/04	MT
Transcript : Revvity, Inc., Q1 2024 Earnings Call, Apr 29, 2024	29/04
Revvity beats quarterly estimates on demand for diagnostic equipment	29/04	RE
Revvity Q1 Adjusted Earnings, Revenue Down; Lowers 2024 Revenue Guidance	29/04	MT
Earnings Flash (RVTY) REVVITY Reports Q1 Revenue $649.9M, vs. Street Est of $647.5M	29/04	MT
Earnings Flash (RVTY) REVVITY Posts Q1 EPS $0.98, vs. Street Est of $0.94	29/04	MT
Revvity, Inc. Updates Earnings Guidance for the Full Year 2024	29/04	CI
Revvity, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	29/04	CI
Revvity, Inc. Declares Quarterly Dividend, Payable on August 9, 2024	26/04	CI
Early Check Newborn Screening Study Taps Revvity to Provide Genome Sequencing	25/04	CI
Declaration of Voting Results by Revvity, Inc	25/04	CI
Revvity Unveils A New Era of Automated Tuberculosis Testing	24/04	CI
Bernstein Adjusts Price Target on Revvity to $125 From $126	22/04	MT
Baird Adjusts Price Target on Revvity to $126 From $123	22/04	MT
Revvity Says Court Issued Preliminary Injunction Against Cloud Software Group	03/04	MT
Revvity Says Court Issued Preliminary Injunction Against Cloud Software Group	02/04	MT
Revvity Files Lawsuit Against Partner Cloud Software Group, Reaffirms 2024 Guidance	21/03	MT
Revvity, Inc. Re-Affirms Earnings Guidance for the Full Year 2024	21/03	CI
Transcript : Revvity, Inc. Presents at KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum, Mar-20-2024 09:00 AM	20/03

Revvity, Inc. (formerly PerkinElmer, Inc.) specializes in designing, manufacturing, and marketing measurement devices and analytical instruments for the healthcare, environmental, scientific research, industry and food sectors. Net sales (including intragroup) break down by family of products as follows: - medical diagnosis equipment (61%); - analytical tools and instruments (39%): biological molecular research tools, thermal analysis software, chemical and environmental measurement tools, genetic screening instruments, reagents, etc. Net sales are distributed geographically as follows: the United States (46.7%), China (14.4%), the United Kingdom (4.1%) and other (34.8%).

Sector

Advanced Medical Equipment & Technology

Calendar

19/07/2024 - Détachement de

Related indices

S&P 500

More about the company

Income Statement Evolution

More financial data

Ratings for Revvity, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

B+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

108.6 USD

Average target price

124.1 USD

Spread / Average Target

+14.22%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
REVVITY, INC.	-0.60%	1.34TCr
THERMO FISHER SCIENTIFIC	+7.77%	22TCr
DANAHER CORPORATION	+10.16%	19TCr
INTUITIVE SURGICAL, INC.	+26.21%	15TCr
BOSTON SCIENTIFIC CORPORATION	+32.78%	11TCr
SIEMENS HEALTHINEERS AG	+0.95%	6.4TCr
EDWARDS LIFESCIENCES CORPORATION	+14.48%	5.26TCr
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+2.92%	4.99TCr
AGILENT TECHNOLOGIES, INC.	-6.60%	3.79TCr
GE HEALTHCARE TECHNOLOGIES INC.	-1.07%	3.49TCr

Other Advanced Medical Equipment & Technology

Revvity, Inc.

Equities

RVTY

US7140461093

Advanced Medical Equipment & Technology

PerkinElmer, Inc. Provides Earnings Guidance for the Full Year 2019

Latest news about Revvity, Inc.

Chart Revvity, Inc.

Company Profile

Income Statement Evolution

Ratings for Revvity, Inc.

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Advanced Medical Equipment & Technology